Intravenous nanocrystals: fabrication, solidification, in vivo fate, and applications for cancer therapy

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi: 10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Jung W, Kwon J, Cho W, et al. Chiral biomaterials for Nanomedicines: from molecules to Supraparticles. Pharmaceutics. 2022;14(9):1951. doi: 10.3390/pharmaceutics14091951
   PubMed Web of Science ®Google Scholar
• Jermain SV, Brough C, Williams RO 3rd. Amorphous solid dispersions and nanocrystals technologies for poorly water-soluble drug delivery - an update. Int J Pharm. 2018;535(1–2):379–392. doi: 10.1016/j.ijpharm.2017.10.051
   PubMedGoogle Scholar
• Ma Y, Cong Z, Gao P, et al. Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate. Eur J Pharm Sci. 2023;185:106425. doi: 10.1016/j.ejps.2023.106425
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ouyang Z, Du H, et al. New opportunities and challenges of natural products research: when target identification meets single-cell multiomics. Acta Pharm Sin B. 2022;12(11):4011–4039. doi: 10.1016/j.apsb.2022.08.022
   PubMed Web of Science ®Google Scholar
• Yeom J, Guimaraes PPG, Ahn HM, et al. Chiral supraparticles for controllable Nanomedicine. Adv Mater. 2020;32(1):e1903878. doi: 10.1002/adma.201903878
   PubMed Web of Science ®Google Scholar
• Dhaval M, Makwana J, Sakariya E, et al. Drug nanocrystals: a comprehensive review with Current regulatory guidelines. Curr Drug Deliv. 2020;17(6):470–482. doi: 10.2174/1567201817666200512104833
   PubMed Web of Science ®Google Scholar
• Li J, Wang Z, Zhang H, et al. Progress in the development of stabilization strategies for nanocrystals preparations. Drug Deliv. 2021;28(1):19–36. doi: 10.1080/10717544.2020.1856224
   PubMed Web of Science ®Google Scholar
• Ren X, Qi J, Wu W, et al. Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation. Acta Pharm Sin B. 2019;9(1):118–127. doi: 10.1016/j.apsb.2018.05.004
   PubMed Web of Science ®Google Scholar
• Yang X, Liu Y, Zhao Y, et al. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Int J Nanomedicine. 2016;11:2979–2994. doi: 10.2147/IJN.S102726
   PubMed Web of Science ®Google Scholar
• Liu F, Park JY, Zhang Y, et al. Targeted cancer therapy with novel high drug-loading nanocrystals. J Pharm Sci. 2010;99(8):3542–3551. doi: 10.1002/jps.22112
   PubMed Web of Science ®Google Scholar
• Yang L, Hong J, Di J, et al. 10-hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG(1000)-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy. Int J Nanomedicine. 2017;12:3681–3695. doi: 10.2147/IJN.S134005
   PubMed Web of Science ®Google Scholar
• Park J, Sun B, Yeo Y. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel. J Control Release. 2017;263:90–101.
   PubMed Web of Science ®Google Scholar
• Mei D, Gong LD, Zou YR, et al. Platelet membrane-cloaked paclitaxel- nanocrystals augment postoperative chemotherapeutical efficacy. J Controll Release. 2020;324:341–353. doi: 10.1016/j.jconrel.2020.05.016
   PubMed Web of Science ®Google Scholar
• Kalhapure RS, Palekar S, Patel K, et al. Nanocrystals for controlled delivery: state of the art and approved drug products. Expert Opin Drug Deliv. 2022;19(10):1303–1316. doi: 10.1080/17425247.2022.2110579
   PubMed Web of Science ®Google Scholar
• Bai M, Yang M, Gong J, et al. Progress and principle of drug INCs for tumor targeted delivery. AAPS Pharm Sci Tech. 2021;23(1):41. doi: 10.1208/s12249-021-02200-w
   PubMed Web of Science ®Google Scholar
• Soisuwan S, Teeranachaideekul V, Wongrakpanich A, et al. Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals. Eur J Pharm Biopharm. 2019;137:68–76. doi: 10.1016/j.ejpb.2019.02.004
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Y, Yue PF, et al. A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production - a case study with ursodeoxycholic acid. Pharm Dev Technol. 2014;19(6):662–670. doi: 10.3109/10837450.2013.819015
   PubMed Web of Science ®Google Scholar
• Sreeharsha N, Prasanthi S, Mahalakshmi S, et al. Enhancement of anti-tumoral properties of paclitaxel nano-crystals by conjugation of Folic acid to pluronic F127: formulation optimization. Vitro And In Vivo Study Molecules. 2022;27(22):7914. doi: 10.3390/molecules27227914
   PubMed Web of Science ®Google Scholar
• Zingale E, Bonaccorso A, Carbone C, et al. Drug nanocrystals: focus on brain delivery from therapeutic to diagnostic applications. Pharmaceutics. 2022;14(4):691. doi: 10.3390/pharmaceutics14040691
   PubMed Web of Science ®Google Scholar
• Mohammad IS, Hu H, Yin L, et al. Drug nanocrystals: fabrication methods and promising therapeutic applications. Int J Pharm. 2019;562:187–202. doi: 10.1016/j.ijpharm.2019.02.045
   PubMedGoogle Scholar
• Wang J, Muhammad N, Li T, et al. Hyaluronic acid-coated camptothecin nanocrystals for targeted drug delivery to enhance anticancer efficacy. Mol Pharm. 2020;17(7):2411–2425. doi: 10.1021/acs.molpharmaceut.0c00161
   PubMedGoogle Scholar
• Muller RH, Gohla S, Keck CM. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78(1):1–9. doi: 10.1016/j.ejpb.2011.01.007
   PubMed Web of Science ®Google Scholar
• Liu T, Yu XX, Yin HP, et al. Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery. Drug Deliv. 2019;26(1):1092–1103. doi: 10.1080/10717544.2019.1682721
   PubMed Web of Science ®Google Scholar
• Peltonen L, Hirvonen J. Drug nanocrystals - versatile option for formulation of poorly soluble materials. Int J Pharm. 2018;537(1–2):73–83. doi: 10.1016/j.ijpharm.2017.12.005
   PubMedGoogle Scholar
• Chen ML, John M, Lee SL, et al. Development considerations for nanocrystal drug products. AAPS J. 2017;19(3):642–651. doi: 10.1208/s12248-017-0064-x
   PubMed Web of Science ®Google Scholar
• Patel D, Zode SS, Bansal AK. Formulation aspects of intravenous nanosuspensions. Int J Pharm. 2020;586:119555. doi: 10.1016/j.ijpharm.2020.119555
   PubMed Web of Science ®Google Scholar
• Chen Z, Wu W, Lu Y. What is the future for nanocrystals-based drug-delivery systems? Ther Deliv. 2020;11(4):225–229. doi: 10.4155/tde-2020-0016
   PubMed Web of Science ®Google Scholar
• Chai Z, Ran D, Lu L, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to Glioma. ACS Nano. 2019;13(5):5591–5601. doi: 10.1021/acsnano.9b00661
   PubMed Web of Science ®Google Scholar
• Boushehri MAS, Dietrich D, Lamprecht A. Nanotechnology as a platform for the development of injectable parenteral formulations: a comprehensive review of the know-hows and state of the art. Pharmaceutics. 2020;12(6):510. doi: 10.3390/pharmaceutics12060510
   PubMed Web of Science ®Google Scholar
• Wong J, Brugger A, Khare A, et al. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Delivery Rev. 2008;60(8):939–954. doi: 10.1016/j.addr.2007.11.008
   PubMed Web of Science ®Google Scholar
• Pawar VK, Singh Y, Meher JG, et al. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014;183:51–66. doi: 10.1016/j.jconrel.2014.03.030
   PubMed Web of Science ®Google Scholar
• Gadalla HH, Lee S, Kim H, et al. Size optimization of carfilzomib nanocrystals for systemic delivery to solid tumors. J Control Release. 2022;352:637–651. doi: 10.1016/j.jconrel.2022.10.041
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng Y, Zhang L, et al. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172(3):1126–1141. doi: 10.1016/j.jconrel.2013.08.006
   PubMed Web of Science ®Google Scholar
• Ahire E, Thakkar S, Darshanwad M, et al. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Acta Pharm Sin B. 2018;8(5):733–755. doi: 10.1016/j.apsb.2018.07.011
   PubMed Web of Science ®Google Scholar
• He W, Zhang J, Ju J, et al. Preparation, characterization, and evaluation of the antitumor effect of kaempferol nanosuspensions. Drug Deliv Transl Res. 2023;13(11):2885–2902. doi: 10.1007/s13346-023-01357-0
   PubMed Web of Science ®Google Scholar
• Long J, Song J, Zhang X, et al. Tea saponins as natural stabilizers for the production of hesperidin nanosuspensions. Int J Pharm. 2020;583:119406. doi: 10.1016/j.ijpharm.2020.119406
   PubMedGoogle Scholar
• Frank KJ, Boeck G. Development of a nanosuspension for iv administration: from miniscale screening to a freeze dried formulation. Eur J Pharm Sci. 2016;87:112–117. doi: 10.1016/j.ejps.2016.03.003
   PubMed Web of Science ®Google Scholar
• Kim W, Ly NK, He Y, et al. Protein corona: friend or foe? co-opting serum proteins for nanoparticle delivery. Adv Drug Deliv Rev. 2023;192:114635. doi: 10.1016/j.addr.2022.114635
   PubMed Web of Science ®Google Scholar
• Luo Z, Lu L, Xu W, et al. In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy. J Control Release. 2022;346:32–42. doi: 10.1016/j.jconrel.2022.03.058
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Skantze P, Skantze U, et al. Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice. Int J Pharm. 2017 May 30;524(1–2):248–256. doi: 10.1016/j.ijpharm.2017.03.062
   PubMedGoogle Scholar
• Zong L, Li X, Wang H, et al. Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(beta-benzyl-l-aspartate) (PEG-PBLA). Int J Pharm. 2017;531(1):108–117. doi: 10.1016/j.ijpharm.2017.08.082
   PubMedGoogle Scholar
• Manaargadoo-Catin M, Ali-Cherif A, Pougnas JL, et al. Hemolysis by surfactants–A review. Adv Colloid Interface Sci. 2016;228:1–16. doi: 10.1016/j.cis.2015.10.011
   PubMed Web of Science ®Google Scholar
• Ancic D, Orsolic N, Odeh D, et al. Resveratrol and its nanocrystals: a promising approach for cancer therapy? Toxicol Appl Pharmacol. 2022;435:435. doi: 10.1016/j.taap.2021.115851
   Web of Science ®Google Scholar
• Wu Q, Tong L, Zou ZR, et al. Herceptin-functionalized SK-BR-3 cell membrane-wrapped paclitaxel nanocrystals for enhancing the targeted therapy effect of HER2-positive breast cancer. Mater Des. 2022;219:110818. doi: 10.1016/j.matdes.2022.110818
   Web of Science ®Google Scholar
• Huang TT, Wang Y, Shen YP, et al. Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo. Sci Rep. 2020;10(1). doi: 10.1038/s41598-020-65773-9
   Web of Science ®Google Scholar
• Fu J, Lu L, Li M, et al. A γ-glutamyl transpeptidase (GGT)-triggered charge reversal drug-delivery system for cervical cancer treatment: In Vitro and in vivo investigation. Pharmaceutics. 2023;15(5):1335. doi: 10.3390/pharmaceutics15051335
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, et al. Drug nanocrystals: in vivo performances. J Control Release. 2012;160(3):418–430. doi: 10.1016/j.jconrel.2012.03.013
   PubMed Web of Science ®Google Scholar
• Bernal-Chavez SA, Del Prado-Audelo ML, Caballero-Floran IH, et al. Insights into terminal sterilization processes of nanoparticles for biomedical applications. Molecules. 2021;26(7):2068. doi: 10.3390/molecules26072068
   PubMed Web of Science ®Google Scholar
• Pengnam S, Charoensuksai P, Yingyongnarongkul BE, et al. siRNA targeting mcl-1 potentiates the anticancer activity of andrographolide nanosuspensions via apoptosis in breast cancer cells. Pharmaceutics. 2022;14(6):1196. doi: 10.3390/pharmaceutics14061196
   PubMed Web of Science ®Google Scholar
• Wang LL, Du J, Zhou YQ, et al. Safety of nanosuspensions in drug delivery. Nanomed-Nanotechnol. 2017;13(2):455–469. doi: 10.1016/j.nano.2016.08.007
   PubMed Web of Science ®Google Scholar
• Fontana F, Figueiredo P, Zhang P, et al. Production of pure drug nanocrystals and nano co-crystals by confinement methods. Adv Drug Deliv Rev. 2018;131:3–21. doi: 10.1016/j.addr.2018.05.002
   PubMed Web of Science ®Google Scholar
• Funahashi I, Kondo K, Ito Y, et al. Novel contamination-free wet milling technique using ice beads for poorly water-soluble compounds. Int J Pharm. 2019;563:413–425. doi: 10.1016/j.ijpharm.2019.04.008
   PubMed Web of Science ®Google Scholar
• Siewert C, Moog R, Alex R, et al. Process and scaling parameters for wet media milling in early phase drug development: a knowledge based approach. Eur J Pharm Sci. 2018;115:126–131. doi: 10.1016/j.ejps.2017.12.022
   PubMed Web of Science ®Google Scholar
• Juhnke M, Märtin D, John E. Generation of wear during the production of drug nanosuspensions by wet media milling. Eur J Pharm Biopharm. 2012;81(1):214–. doi: 10.1016/j.ejpb.2012.01.005
   PubMed Web of Science ®Google Scholar
• Nakach M, Authelin JR, Perrin MA, et al. Comparison of high pressure homogenization and stirred bead milling for the production of nano-crystalline suspensions. Int J Pharm. 2018;547(1–2):61–71. doi: 10.1016/j.ijpharm.2018.05.042
   PubMedGoogle Scholar
• Ma P, Seguin J, Ly NK, et al. Designing fisetin nanocrystals for enhanced in cellulo anti-angiogenic and anticancer efficacy. Int J Pharm X. 2022;4:100138. doi: 10.1016/j.ijpx.2022.100138
   PubMedGoogle Scholar
• Padrela L, Rodrigues MA, Duarte A, et al. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - a comprehensive review. Adv Drug Deliv Rev. 2018;131:22–78. doi: 10.1016/j.addr.2018.07.010
   PubMed Web of Science ®Google Scholar
• Pinar SG, Oktay AN, Karakucuk AE, et al. Formulation strategies of nanosuspensions for various administration routes. Pharmaceutics. 2023;15(5):1520. doi: 10.3390/pharmaceutics15051520
   PubMed Web of Science ®Google Scholar
• Salazar J, Müller RH, Möschwitzer JP. Combinative particle size Reduction technologies for the production of drug nanocrystals. J Pharm (Cairo). 2014;2014:265754. doi: 10.1155/2014/265754
   PubMedGoogle Scholar
• Kalvakuntla S, Deshpande M, Attari Z, et al. Preparation and characterization of nanosuspension of Aprepitant by H96 process. Adv Pharm Bull. 2016;6(1):83–90. doi: 10.15171/apb.2016.013
   PubMed Web of Science ®Google Scholar
• Liu T, Müller RH, Möschwitzer JP. Systematical investigation of a combinative particle size reduction technology for production of resveratrol nanosuspensions. AAPS Pharm Sci Tech. 2017;18(5):1683–1691. doi: 10.1208/s12249-016-0612-1
   PubMed Web of Science ®Google Scholar
• Sinha B, Staufenbiel S, Müller RH, et al. Sub-50 nm ultra-small organic drug nanosuspension prepared by cavi-precipitation and its brain targeting potential. Int J Pharm. 2021;607:120983. doi: 10.1016/j.ijpharm.2021.120983
   PubMedGoogle Scholar
• Junghanns JU, Muller RH. INC technology, drug delivery and clinical applications. Int J Nanomedicine. 2008;3(3):295–309. doi: 10.2147/IJN.S595
   PubMed Web of Science ®Google Scholar
• Li M, Yaragudi N, Afolabi A, et al. Sub-100nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification. Chem Eng Sci. 2015 Jul 7;130:207–220. doi: 10.1016/j.ces.2015.03.020
   Web of Science ®Google Scholar
• Peltonen L. Design space and QbD approach for production of drug nanocrystals by wet media milling techniques. Pharmaceutics. 2018;10(3):104. doi: 10.3390/pharmaceutics10030104
   PubMed Web of Science ®Google Scholar
• Ouranidis A, Gkampelis N, Vardaka E, et al. Overcoming the solubility barrier of ibuprofen by the rational process design of a nanocrystal formulation. Pharmaceutics. 2020;12(10):969. doi: 10.3390/pharmaceutics12100969
   PubMed Web of Science ®Google Scholar
• Paredes AJ, Camacho NM, Schofs L, et al. Ricobendazole nanocrystals obtained by media milling and spray drying: pharmacokinetic comparison with the micronized form of the drug. Int J Pharm. 2020;585:119501. doi: 10.1016/j.ijpharm.2020.119501
   PubMed Web of Science ®Google Scholar
• Karadag A, Ozcelik B, Huang Q. Quercetin nanosuspensions produced by high-pressure homogenization. J Agric Food Chem. 2014;62(8):1852–1859. doi: 10.1021/jf404065p
   PubMed Web of Science ®Google Scholar
• Hu X, Chen X, Zhang L, et al. A combined bottom-up/top-down approach to prepare a sterile injectable nanosuspension. Int J Pharm. 2014;472(1–2):130–139. doi: 10.1016/j.ijpharm.2014.06.018
   PubMedGoogle Scholar
• Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24(1):3. doi: 10.1186/s40824-020-0184-8
   PubMedGoogle Scholar
• Sinha B, Muller RH, Moschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm. 2013;453(1):126–141. doi: 10.1016/j.ijpharm.2013.01.019
   PubMed Web of Science ®Google Scholar
• Zhou YQ, Du J, Wang LL, et al. State of the art of nanocrystals technology for delivery of poorly soluble drugs. J Nanopart Res. 2016;18(9). doi: 10.1007/s11051-016-3575-y
   Web of Science ®Google Scholar
• Ali HS, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm. 2009;375(1–2):107–113. doi: 10.1016/j.ijpharm.2009.03.029
   PubMedGoogle Scholar
• Ahmadi Tehrani A, Omranpoor MM, Vatanara A, et al. Formation of nanosuspensions in bottom-up approach: theories and optimization. DARU, J Pharm Sci. 2019;27(1):451–473. doi: 10.1007/s40199-018-00235-2
   Web of Science ®Google Scholar
• Yao L, Zhao X, Li Q, et al. In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity. Int J Pharm. 2012;423(2):586–588. doi: 10.1016/j.ijpharm.2011.11.031
   PubMedGoogle Scholar
• Saadati Ardestani N, Sodeifian G, Sajadian SA. Preparation of phthalocyanine green nano pigment using supercritical CO2 gas antisolvent (GAS): experimental and modeling. Heliyon. 2020;6(9):e04947. doi: 10.1016/j.heliyon.2020.e04947
   PubMed Web of Science ®Google Scholar
• Patel V, Sharma OP, Mehta T. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery. Expert Opin Drug Deliv. 2018;15(4):351–368. doi: 10.1080/17425247.2018.1444025
   PubMed Web of Science ®Google Scholar
• Salazar J, Muller RH, Moschwitzer JP. Combinative particle size reduction technologies for the production of drug nanocrystals. J Pharm (Cairo). 2014;2014:265754. doi: 10.1155/2014/265754
   PubMedGoogle Scholar
• Al Shaal L, Shegokar R, Müller RH. Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int J Pharm. 2011;420(1):133–140. doi: 10.1016/j.ijpharm.2011.08.018
   PubMedGoogle Scholar
• Zhang X, Guan J, Ni R, et al. Preparation and solidification of redispersible nanosuspensions. J Pharm Sci. 2014;103(7):2166–2176. doi: 10.1002/jps.24015
   PubMed Web of Science ®Google Scholar
• Wei Q, Keck CM, Muller RH. Solidification of hesperidin nanosuspension by spray drying optimized by design of experiment (DoE). Drug Dev Ind Pharm. 2018;44(1):1–12. doi: 10.1080/03639045.2017.1285309
   PubMed Web of Science ®Google Scholar
• Medarevic D, Djuris J, Ibric S, et al. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling. Int J Pharm. 2018;540(1–2):150–161. doi: 10.1016/j.ijpharm.2018.02.011
   PubMed Web of Science ®Google Scholar
• Toziopoulou F, Malamatari M, Nikolakakis I, et al. Production of aprepitant nanocrystals by wet media milling and subsequent solidification. Int J Pharm. 2017;533(2):324–334. doi: 10.1016/j.ijpharm.2017.02.065
   PubMed Web of Science ®Google Scholar
• Czyz S, Wewers M, Finke JH, et al. Spray drying of API nanosuspensions: importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development. Eur J Pharm Biopharm. 2020;152:63–71. doi: 10.1016/j.ejpb.2020.04.021
   PubMed Web of Science ®Google Scholar
• Thakkar S, Sharma D, Misra M. Comparative evaluation of electrospraying and lyophilization techniques on solid state properties of Erlotinib nanocrystals: assessment of in-vitro cytotoxicity. Eur J Pharm Sci. 2018;111:257–269. doi: 10.1016/j.ejps.2017.10.008
   PubMed Web of Science ®Google Scholar
• Ho H, Lee J. Redispersible drug nanoparticles prepared without dispersant by electro-spray drying. Drug Dev Ind Pharm. 2012;38(6):744–751. doi: 10.3109/03639045.2011.624522
   PubMed Web of Science ®Google Scholar
• Farooq MA, Jabeen A, Wang B. Formulation, optimization, and characterization of whey protein isolate nanocrystals for celecoxib delivery. J Microencapsul. 2021;38(5):314–323. doi: 10.1080/02652048.2021.1915398
   PubMed Web of Science ®Google Scholar
• Wang L, Ma Y, Gu Y, et al. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers. J Microencapsul. 2018;35(3):241–248. doi: 10.1080/02652048.2018.1462416
   PubMed Web of Science ®Google Scholar
• Sverdlov Arzi R, Sosnik A. Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals. Adv Drug Deliv Rev. 2018;131:79–100. doi: 10.1016/j.addr.2018.07.012
   PubMed Web of Science ®Google Scholar
• Salama AH. Spray drying as an advantageous strategy for enhancing pharmaceuticals bioavailability. Drug Deliv Transl Res. 2020;10(1):1–12. doi: 10.1007/s13346-019-00648-9
   PubMed Web of Science ®Google Scholar
• Ziaee A, Albadarin AB, Padrela L, et al. Spray drying of pharmaceuticals and biopharmaceuticals: critical parameters and experimental process optimization approaches. Eur J Pharm Sci. 2019;127:300–318. doi: 10.1016/j.ejps.2018.10.026
   PubMed Web of Science ®Google Scholar
• Abla KK, Mehanna MM. Freeze-drying: a flourishing strategy to fabricate stable pharmaceutical and biological products. Int J Pharm. 2022;628:122233. doi: 10.1016/j.ijpharm.2022.122233
   PubMedGoogle Scholar
• Mohammady M, Mohammadi Y, Yousefi G. Freeze-drying of pharmaceutical and nutraceutical nanoparticles: the effects of formulation and technique parameters on nanoparticles characteristics. J Pharm Sci. 2020;109(11):3235–3247. doi: 10.1016/j.xphs.2020.07.015
   PubMed Web of Science ®Google Scholar
• Ma YQ, Zhang ZZ, Li G, et al. Solidification drug nanosuspensions into nanocrystals by freeze-drying: a case study with ursodeoxycholic acid. Pharm Dev Technol. 2016;21(2):180–188. doi: 10.3109/10837450.2014.982822
   PubMed Web of Science ®Google Scholar
• Vishali DA, Monisha J, Sivakamasundari SK, et al. Spray freeze drying: emerging applications in drug delivery. J Control Release. 2019;300:93–101. doi: 10.1016/j.jconrel.2019.02.044
   PubMed Web of Science ®Google Scholar
• Schonfeld B, Westedt U, Wagner KG. Vacuum drum drying - a novel solvent-evaporation based technology to manufacture amorphous solid dispersions in comparison to spray drying and hot melt extrusion. Int J Pharm. 2021;596:120233. doi: 10.1016/j.ijpharm.2021.120233
   PubMedGoogle Scholar
• Schonfeld BV, Westedt U, Keller BL, et al. Transformation of ritonavir nanocrystals suspensions into a redispersible drug product via Vacuum drum drying. AAPS Pharm Sci Tech. 2022;23(5):137. doi: 10.1208/s12249-022-02283-z
   PubMed Web of Science ®Google Scholar
• Lu Y, Qi J, Dong X, et al. The in vivo fate of nanocrystals. Drug Discov Today. 2017;22(4):744–750. doi: 10.1016/j.drudis.2017.01.003
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma Y, Xu J, et al. Apolipoproteins adsorption and brain-targeting evaluation of baicalin nanocrystals modified by combination of Tween80 and TPGS. Colloids Surf B Biointerfaces. 2017;160:619–627. doi: 10.1016/j.colsurfb.2017.10.009
   PubMed Web of Science ®Google Scholar
• Guo M, Fu Q, Wu C, et al. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin. Colloids Surf B Biointerfaces. 2015;128:410–418. doi: 10.1016/j.colsurfb.2015.02.039
   PubMed Web of Science ®Google Scholar
• Chu KS, Hasan W, Rawal S, et al. Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine. 2013;9(5):686–693. doi: 10.1016/j.nano.2012.11.008
   PubMed Web of Science ®Google Scholar
• Lv Y, Wu W, Corpstein CD, et al. Biological and intracellular fates of drug nanocrystals through different delivery routes: recent development enabled by bioimaging and PK modeling. Adv Drug Deliv Rev. 2022;188:114466. doi: 10.1016/j.addr.2022.114466
   PubMed Web of Science ®Google Scholar
• Deng F, Zhang H, Wang X, et al. Transmembrane pathways and mechanisms of rod-like paclitaxel nanocrystals through MDCK polarized monolayer. ACS Appl Mater Interfaces. 2017;9(7):5803–5816. doi: 10.1021/acsami.6b15151
   PubMed Web of Science ®Google Scholar
• Sujai PT, Joseph MM, Saranya G, et al. Surface charge modulates the internalization vs. penetration of gold nanoparticles: comprehensive scrutiny on monolayer cancer cells, multicellular spheroids and solid tumors by SERS modality. Nanoscale. 2020;12(13):6971–6975. doi: 10.1039/D0NR00809E
   PubMed Web of Science ®Google Scholar
• Han D, Qi H, Huang K, et al. The effects of surface charge on the intra-tumor penetration of drug delivery vehicles with tumor progression. J Mater Chem B. 2018;6(20):3331–3339. doi: 10.1039/C8TB00038G
   PubMed Web of Science ®Google Scholar
• Chen L, Glass JJ, De Rose R, et al. Influence of charge on hemocompatibility and immunoreactivity of polymeric nanoparticles. ACS Appl Bio Mater. 2018;1(3):756–767. doi: 10.1021/acsabm.8b00220
   PubMedGoogle Scholar
• Bi C, Miao XQ, Chow SF, et al. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. Nanomed-Nanotechnol. 2017;13(3):943–953. doi: 10.1016/j.nano.2016.11.004
   PubMed Web of Science ®Google Scholar
• Zhao JH, Du JL, Wang J, et al. Folic acid and poly(ethylene glycol) decorated paclitaxel INCs exhibit enhanced stability and breast cancer-targeting capability. ACS Appl Mater Inter. 2021;13(12):14590–14599. doi: 10.1021/acsami.1c00184
   Web of Science ®Google Scholar
• Leone F, Cavalli R. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations. Expert Opin Drug Deliv. 2015;12(10):1607–1625. doi: 10.1517/17425247.2015.1043886
   PubMed Web of Science ®Google Scholar
• Hollis CP, Weiss HL, Leggas M, et al. Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J Control Release. 2013;172(1):12–21. doi: 10.1016/j.jconrel.2013.06.039
   PubMed Web of Science ®Google Scholar
• Liu T, Yao G, Liu X, et al. Preparation nanocrystals of poorly soluble plant compounds using an ultra-small-scale approach. AAPS Pharm Sci Tech. 2017;18(7):2610–2617. doi: 10.1208/s12249-017-0742-0
   PubMed Web of Science ®Google Scholar
• Kingston BR, Lin ZP, Ouyang B, et al. Specific endothelial cells govern nanoparticle entry into solid tumors. ACS Nano. 2021;15(9):14080–14094. doi: 10.1021/acsnano.1c04510
   PubMed Web of Science ®Google Scholar
• Zhang J, Corpstein CD, Li T. Intracellular uptake of nanocrystals: probing with aggregation-induced emission of fluorescence and kinetic modeling. Acta Pharm Sin B. 2021;11(4):1021–1029. doi: 10.1016/j.apsb.2020.09.017
   PubMed Web of Science ®Google Scholar
• Han X, Su R, Huang X, et al. Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance. Asian J Pharm Sci. 2019;14(5):569–580. doi: 10.1016/j.ajps.2018.06.006
   PubMed Web of Science ®Google Scholar
• Lu L, Xu Q, Wang J, et al. Drug nanocrystals for active tumor-targeted drug delivery. Pharmaceutics. 2022;14(4):797. doi: 10.3390/pharmaceutics14040797
   PubMed Web of Science ®Google Scholar
• Haddad R, Alrabadi N, Altaani B, et al. Paclitaxel drug delivery systems: focus on nanocrystals’ surface modifications. Polymers. 2022;14(4):658. doi: 10.3390/polym14040658
   PubMed Web of Science ®Google Scholar
• Zhang WS, Mehta A, Tong ZQ, et al. Development of polymeric nanoparticles for blood-brain barrier transfer-strategies and challenges. Adv Sci. 2021;8(10). doi: 10.1002/advs.202003937
   Web of Science ®Google Scholar
• Liu P, Jiang C. Brain-targeting drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(5):e1818. doi: 10.1002/wnan.1818
   PubMed Web of Science ®Google Scholar
• Abouelmagd SA, Sun B, Chang AC, et al. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Mol Pharm. 2015;12(3):997–1003. doi: 10.1021/mp500817h
   PubMed Web of Science ®Google Scholar
• Li W, Li Z, Wei L, et al. Evaluation of paclitaxel nanocrystals in vitro and in vivo. Drug Res (Stuttg). 2018;68(4):205–212. doi: 10.1055/s-0043-119461
   PubMed Web of Science ®Google Scholar
• Hong JY, Sun ZH, Li YJ, et al. Folate-modified annonaceous acetogenins nanosuspensions and their improved antitumor efficacy. Int J Nanomed. 2017;12:5053–5067. doi: 10.2147/IJN.S134284
   PubMed Web of Science ®Google Scholar
• Li HW, Li YJ, Ao H, et al. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice. Drug Deliv. 2018;25(1):880–887. doi: 10.1080/10717544.2018.1455761
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Y, Zhao J, et al. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions. Colloids Surf B Biointerfaces. 2017;160:462–472. doi: 10.1016/j.colsurfb.2017.09.056
   PubMed Web of Science ®Google Scholar
• Zhao J, Du J, Wang J, et al. Folic acid and poly(ethylene glycol) decorated paclitaxel nanocrystals exhibit enhanced stability and breast cancer-targeting capability. ACS Appl Mater Interfaces. 2021;13(12):14577–14586. Epub 20210317. doi: 10.1021/acsami.1c00184
   PubMed Web of Science ®Google Scholar
• Agrawal S, Dwivedi M, Ahmad H, et al. CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer. Nanomed-Nanotechnol. 2018;14(2):327–337. doi: 10.1016/j.nano.2017.10.010
   PubMed Web of Science ®Google Scholar
• Sharma S, Singh J, Verma A, et al. Hyaluronic acid anchored paclitaxel nanocrystals improves chemotherapeutic efficacy and inhibits lung metastasis in tumor-bearing rat model. RSC Adv. 2016;6(77):73083–73095. doi: 10.1039/C6RA11260A
   Web of Science ®Google Scholar
• Choi JS, Park JS. Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells. Colloids Surf B Biointerfaces. 2017;159:139–150. doi: 10.1016/j.colsurfb.2017.07.064
   PubMed Web of Science ®Google Scholar
• Huang ZG, Lv FM, Wang J, et al. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. Int J Pharm. 2019;556:217–225. doi: 10.1016/j.ijpharm.2018.12.023
   PubMed Web of Science ®Google Scholar
• Choi JS, Park JS. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting. Drug Des Devel Ther. 2017;11:17–26. doi: 10.2147/DDDT.S122984
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang ZH, Li T, et al. Development and evaluation of transferrin-stabilized paclitaxel INC formulation. J Control Release. 2014;176:76–85. doi: 10.1016/j.jconrel.2013.12.018
   PubMed Web of Science ®Google Scholar
• Sohn JS, Yoon DS, Sohn JY, et al. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals. Mater Sci Eng C Mater Biol Appl. 2017;72:228–237. doi: 10.1016/j.msec.2016.11.065
   PubMed Web of Science ®Google Scholar
• Zou S, Wang B, Wang C, et al. Cell membrane-coated nanoparticles: research advances. Nanomedicine (Lond). 2020;15(6):625–641. doi: 10.2217/nnm-2019-0388
   PubMed Web of Science ®Google Scholar
• Rovati G, Contursi A, Bruno A, et al. Antiplatelet agents affecting GPCR signaling implicated in tumor metastasis. Cells-Basel. 2022;11(4):725. doi: 10.3390/cells11040725
   PubMed Web of Science ®Google Scholar
• Xiao G, Zhang Z, Chen Q, et al. Platelets for cancer treatment and drug delivery. Clin Transl Oncol. 2022;24(7):1231–1237. doi: 10.1007/s12094-021-02771-x
   PubMed Web of Science ®Google Scholar
• Fan YY, Cui YX, Hao WY, et al. Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma. Bioact Mater. 2021;6(12):4402–4414. doi: 10.1016/j.bioactmat.2021.04.027
   PubMed Web of Science ®Google Scholar
• Fan YY, Hao WY, Cui YX, et al. Cancer cell membrane-coated nanosuspensions for enhanced chemotherapeutic treatment of glioma. Molecules. 2021;26(16):5103. doi: 10.3390/molecules26165103
   PubMed Web of Science ®Google Scholar
• Harris JC, Scully MA, Day ES. Cancer cell membrane-coated nanoparticles for cancer management. Cancers (Basel). 2019;11(12):1836. doi: 10.3390/cancers11121836
   PubMed Web of Science ®Google Scholar
• Shen W, Ge S, Liu X, et al. Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma. Drug Deliv. 2022;29(1):31–42. doi: 10.1080/10717544.2021.2015481
   PubMed Web of Science ®Google Scholar
• Hao WY, Cui YX, Fan YY, et al. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery. J Nanobiotechnol. 2021;19(1). doi: 10.1186/s12951-021-01110-0
   Web of Science ®Google Scholar
• Zhao YA, Li AX, Jiang LD, et al. Hybrid membrane-coated biomimetic nanoparticles (hm@bnps): a multifunctional nanomaterial for biomedical applications. Biomacromolecules. 2021;22(8):3149–3167. doi: 10.1021/acs.biomac.1c00440
   PubMed Web of Science ®Google Scholar
• Park JE, Park J, Jun Y, et al. Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystals formulation. J Control Release. 2019;302:148–159. doi: 10.1016/j.jconrel.2019.04.006
   PubMed Web of Science ®Google Scholar
• Kanamala M, Palmer BD, Wilson WR, et al. Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes. Int J Pharm. 2018;548(1):288–296. doi: 10.1016/j.ijpharm.2018.07.009
   PubMedGoogle Scholar
• Hoang Thi TT, Pilkington EH, Nguyen DH, et al. The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation. Polymers. 2020;12(2):298. doi: 10.3390/polym12020298
   PubMed Web of Science ®Google Scholar
• Ai X, Wang S, Duan Y, et al. Emerging approaches to functionalizing cell membrane-coated nanoparticles. Biochemistry. 2021;60(13):941–955. doi: 10.1021/acs.biochem.0c00343
   PubMed Web of Science ®Google Scholar
• Yin T, Dong L, Cui B, et al. A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy. Int J Nanomedicine. 2015;10:7397–7412. doi: 10.2147/IJN.S92697
   PubMed Web of Science ®Google Scholar
• Ying M, Zhuang J, Wei X, et al. Remote-loaded platelet vesicles for disease-targeted delivery of therapeutics. Adv Funct Mater. 2018;28(22). doi: 10.1002/adfm.201801032
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun W, Wang J, et al. Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy. Nat Biomed Eng. 2018;2(11):831–840. doi: 10.1038/s41551-018-0310-2
   PubMed Web of Science ®Google Scholar
• Shiekhzadeh A, Sohrabi N, Moghadam ME, et al. Kinetic and thermodynamic investigation of human serum albumin Interaction with anticancer glycine derivative of platinum complex by using spectroscopic methods and molecular docking. Appl Biochem Biotechnol. 2020;190(2):506–528. doi: 10.1007/s12010-019-03078-y
   PubMed Web of Science ®Google Scholar
• Yin T, Cai H, Liu J, et al. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel. Eur J Pharm Sci. 2016;83:79–87. doi: 10.1016/j.ejps.2015.12.019
   PubMed Web of Science ®Google Scholar
• Hollis CP, Dozier AK, Knutson BL, et al. Preparation and characterization of multimodal hybrid organic and inorganic nanocrystals of camptothecin and gold. Acta Pharm Sin B. 2019;9(1):128–134. doi: 10.1016/j.apsb.2018.03.005
   PubMed Web of Science ®Google Scholar
• Lu Y, Lv Y, Li T. Hybrid drug nanocrystals. Adv Drug Deliv Rev. 2019;143:115–133. doi: 10.1016/j.addr.2019.06.006
   PubMed Web of Science ®Google Scholar
• Zhao R, Hollis CP, Zhang H, et al. Hybrid nanocrystals: achieving concurrent therapeutic and bioimaging functionalities toward solid tumors. Mol Pharm. 2011;8(5):1985–1991. doi: 10.1021/mp200154k
   PubMedGoogle Scholar
• Hollis CP, Weiss HL, Evers BM, et al. In vivo investigation of hybrid paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics. Pharm Res. 2014;31(6):1450–1459. doi: 10.1007/s11095-013-1048-x
   PubMed Web of Science ®Google Scholar
• Gao W, Lee D, Meng Z, et al. Exploring intracellular fate of drug nanocrystals with crystal-integrated and environment-sensitive fluorophores. J Control Release. 2017;267:214–222. doi: 10.1016/j.jconrel.2017.08.031
   PubMed Web of Science ®Google Scholar
• Hu X, Dong X, Lu Y, et al. Bioimaging of nanoparticles: the crucial role of discriminating nanoparticles from free probes. Drug Discov Today. 2017;22(2):382–387. doi: 10.1016/j.drudis.2016.10.002
   PubMed Web of Science ®Google Scholar
• Xie Y, Shi B, Xia F, et al. Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies. J Control Release. 2018;270:65–75. doi: 10.1016/j.jconrel.2017.11.046
   PubMed Web of Science ®Google Scholar
• Shen C, Yang Y, Shen B, et al. Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery. Nanoscale. 2017;10(1):436–450. doi: 10.1039/C7NR06052A
   PubMed Web of Science ®Google Scholar
• Hou YJ, Yang XX, Liu RQ, et al. Pathological mechanism of photodynamic therapy and photothermal therapy based on nanoparticles. Int J Nanomedicine. 2020;15:6827–6838. doi: 10.2147/IJN.S269321
   PubMed Web of Science ®Google Scholar
• Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098–1107. doi: 10.1016/j.biopha.2018.07.049
   PubMed Web of Science ®Google Scholar
• Fang X, Xie A, Song H, et al. A novel alpha-(8-quinolinyloxy) monosubstituted zinc phthalocyanine nanosuspension for potential enhanced photodynamic therapy. Drug Dev Ind Pharm. 2020;46(11):1881–1888. doi: 10.1080/03639045.2020.1825474
   PubMed Web of Science ®Google Scholar
• Jakhmola A, Krishnan S, Onesto V, et al. Sustainable synthesis and theoretical studies of polyhedral gold nanoparticles displaying high SERS activity, NIR absorption, and cellular uptake. Mater Today Chem. 2022;26:101016. doi: 10.1016/j.mtchem.2022.101016
   Web of Science ®Google Scholar
• Gerosa C, Crisponi G, Nurchi VM, et al. Gold nanoparticles: a New Golden Era in oncology? Pharmaceuticals (Basel). 2020;13(8):192. doi: 10.3390/ph13080192
   PubMedGoogle Scholar
• Vallabani NVS, Singh S, Karakoti AS. Magnetic nanoparticles: Current trends and future aspects in diagnostics and Nanomedicine. Curr Drug Metab. 2019;20(6):457–472. doi: 10.2174/1389200220666181122124458
   PubMed Web of Science ®Google Scholar
• Wu K, Su D, Liu J, et al. Magnetic nanoparticles in nanomedicine: a review of recent advances. Nanotechnology. 2019;30(50):502003. doi: 10.1088/1361-6528/ab4241
   PubMed Web of Science ®Google Scholar
• Du Y, Liu X, Liang Q, et al. Optimization and design of magnetic ferrite nanoparticles with uniform tumor distribution for highly sensitive MRI/MPI performance and improved magnetic hyperthermia therapy. Nano Lett. 2019;19(6):3618–3626. doi: 10.1021/acs.nanolett.9b00630
   PubMed Web of Science ®Google Scholar
• Xie J, Zhang Y, Yan C, et al. High-performance PEGylated Mn-Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics. Biomaterials. 2014;35(33):9126–9136. doi: 10.1016/j.biomaterials.2014.07.019
   PubMed Web of Science ®Google Scholar
• Xie J, Yan C, Yan Y, et al. Multi-modal Mn-Zn ferrite nanocrystals for magnetically-induced cancer targeted hyperthermia: a comparison of passive and active targeting effects. Nanoscale. 2016;8(38):16902–16915. doi: 10.1039/C6NR03916B
   PubMed Web of Science ®Google Scholar
• Wang C, Hsu CH, Li Z, et al. Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia. Int J Nanomedicine. 2017;12:6273–6287. doi: 10.2147/IJN.S141072
   PubMed Web of Science ®Google Scholar
• Liu S, Shi D, Chen L, et al. Paclitaxel-loaded magnetic nanocrystals for tumor neovascular-targeted theranostics: an amplifying synergistic therapy combining magnetic hyperthermia with chemotherapy. Nanoscale. 2021;13(6):3613–3626. doi: 10.1039/D0NR08197C
   PubMed Web of Science ®Google Scholar